VAERS 2549000
PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN9269
- Staat
- NY
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 03.01.2023
- Impfdatum
- 30.09.2022
- Beginn
- 04.10.2022
- Tage bis Beginn
- 4,0
- Dosis
- 2
- Route/Site
- IM / LA
Symptomtext
10/4/2022-Presents to ED via EMS, with reports of AMS, only responsive to painful stimuli. Ordered ceftriaxone, UTI. Trop peaked at 0.144 consistent with a Type 2 NSTEMI, recieved asa and on Heparin drip. Covid - test. Recent admission 9/11-9/23/2022 for acute hypoxic resp failure PNA. VSS 02 94% on RA. CXR-bibasilar airspace disease. Admit metabolic encephalopathy in setting of UTI. 10/7/2022-BP elevated 181/66 Hydralazine added. Desat 85% 4L via NC placed. Ceftriaxone changed to Unasyn, to cover for aspiration. 10/10/2022-UC yeast and VRE. restart oxybutin and start linezolid and fluconazole. Now covid +. 10/12/2022- Continue on bumex, isodil and Procardia. On RA VSS. CXR-b/l pulm infiltrates. Reanla dysfunction 10/12/2022- does not permit to use remdesivir or baricitinib. 10/13/2022- O2 increased to 6L nc after desat of 87%. Unasyn changed to Zosyn. Dexamethasone started. 10/14/2022-O2 increased to 8L NC. 10/15/2022- o2 increased to 15 L NRB, made palliative. Time of death 2056.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- 11,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Type 1 DM, HTN, CAD and CKD.
- Andere Medikamente
- -
- Allergien
- Codeine
- Vorherige Impfungen
- -